IPO - QXO, Inc.

Form Type: 8-K

Filing Date: 2025-05-23

Corporate Action: Ipo

Type: New

Accession Number: 000110465925052221

Filing Summary: On May 21, 2025, QXO, Inc. entered into an underwriting agreement with Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC to sell 48,484,849 shares of its common stock at a public offering price of $16.50 per share. The underwriters were given an option to purchase an additional 7,272,727 shares, which was exercised in full. The expected net proceeds from the offering are approximately $892.8 million after deducting underwriting discounts and commissions. The offering was made under the company’s registration statement on Form S-3ASR, and a preliminary prospectus was filed with the SEC on May 20, 2025, followed by a final prospectus supplement dated May 21, 2025. A press release announcing the pricing of the offering was issued on May 22, 2025.

Form Type: 8-K

Filing Date: 2025-05-20

Corporate Action: Ipo

Type: New

Accession Number: 000110465925051009

Filing Summary: On May 20, 2025, QXO, Inc. announced its intention to offer for sale to the public through concurrent separate underwritten public offerings of its common stock and depositary shares representing a 1/20th interest in a share of new Series B Mandatory Convertible Preferred Stock. The gross proceeds from these offerings are expected to reach $1.0 billion, with potential additional proceeds of $150 million from over-allotment options granted to underwriters. Each offering will close independently of the other.

Form Type: 8-K

Filing Date: 2025-04-21

Corporate Action: Ipo

Type: New

Accession Number: 000095014225001119

Filing Summary: On April 16, 2025, QXO, Inc. entered into an underwriting agreement with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC to sell 37,735,850 shares of its common stock at a public offering price of $13.25 per share. The company granted the underwriters an option to purchase an additional 5,660,377 shares. Net proceeds from the offering are expected to be approximately $490 million, or about $564.2 million if the option is exercised in full. The offering was registered under Form S-3ASR and was supported by a preliminary and final prospectus supplement filed with the SEC. Additionally, on the same date, QXO released a press release announcing the pricing of the offering and a legal opinion regarding the legality of the common stock sold was included as an exhibit.

Form Type: 8-K

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: New

Accession Number: 000095014225001090

Filing Summary: On April 16, 2025, QXO, Inc. announced its intention to offer for sale to the public $500,000,000 of shares of its common stock, with an additional option for underwriters to purchase up to $75,000,000 of shares at the same price per share. This move signifies a significant step towards raising capital through an initial public offering (IPO), aimed at expanding its business operations. A press release detailing this announcement is included as an exhibit.